Gizmodo

Pharma Bro Martin Shkreli Could Be in Big Trouble Again

The FTC says he's been trading pharma stocks. He's banned for life.

Via Gizmodo

Oct 13, 2026·Excerpt

Pharma Bro Martin Shkreli Could Be in Big Trouble Again — Image: Martin Shkreli smiles while speaking to the media in front of U.S. District Court for the Eastern District of New York with members of his legal team after the jury issued a verdict, August 4, 2017 in the Brooklyn borough of New York City. © Photo by Spencer Platt/Getty Images

The Federal Trade Commission has asked a federal judge to hold Martin Shkreli, the former pharmaceutical executive better known as “Pharma Bro” in the 2010s, in contempt of court for allegedly publicly trading in pharmaceutical industry stocks and giving his opinion on the pharma industry, according to a press release from the federal agency.

Shkreli first became internet famous after raising the price of a life-saving drug Daraprim from $13.50 to $750 a pill and bragging about how that just…

Continue reading on Gizmodo ↗

Courtesy

This story was originally published by Gizmodo. All rights belong to the original publisher.

Read the original on gizmodo.com ↗

Pharma Bro Martin Shkreli Could Be in Big Trouble Again

Courtesy

Have a story tip, correction or partnership idea?